These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 29511103)
1. Susceptibility of brain atrophy to Lorenzi M; Altmann A; Gutman B; Wray S; Arber C; Hibar DP; Jahanshad N; Schott JM; Alexander DC; Thompson PM; Ourselin S; Proc Natl Acad Sci U S A; 2018 Mar; 115(12):3162-3167. PubMed ID: 29511103 [TBL] [Abstract][Full Text] [Related]
2. Hippocampal Sclerosis of Aging, a Common Alzheimer's Disease 'Mimic': Risk Genotypes are Associated with Brain Atrophy Outside the Temporal Lobe. Nho K; Saykin AJ; ; Nelson PT J Alzheimers Dis; 2016; 52(1):373-83. PubMed ID: 27003218 [TBL] [Abstract][Full Text] [Related]
3. Multiple genetic imaging study of the association between cholesterol metabolism and brain functional alterations in individuals with risk factors for Alzheimer's disease. Bai F; Yuan Y; Shi Y; Zhang Z Oncotarget; 2016 Mar; 7(13):15315-28. PubMed ID: 26985771 [TBL] [Abstract][Full Text] [Related]
4. Mining Outcome-relevant Brain Imaging Genetic Associations via Three-way Sparse Canonical Correlation Analysis in Alzheimer's Disease. Hao X; Li C; Du L; Yao X; Yan J; Risacher SL; Saykin AJ; Shen L; Zhang D; Sci Rep; 2017 Mar; 7():44272. PubMed ID: 28291242 [TBL] [Abstract][Full Text] [Related]
5. Imaging genomics discovery of a new risk variant for Alzheimer's disease in the postsynaptic SHARPIN gene. Soheili-Nezhad S; Jahanshad N; Guelfi S; Khosrowabadi R; Saykin AJ; Thompson PM; Beckmann CF; Sprooten E; Zarei M; Hum Brain Mapp; 2020 Sep; 41(13):3737-3748. PubMed ID: 32558014 [TBL] [Abstract][Full Text] [Related]
6. Identifying the joint signature of brain atrophy and gene variant scores in Alzheimer's Disease. Cruciani F; Aparo A; Brusini L; Combi C; Storti SF; Giugno R; Menegaz G; Boscolo Galazzo I; J Biomed Inform; 2024 Jan; 149():104569. PubMed ID: 38104851 [TBL] [Abstract][Full Text] [Related]
7. Linking Genetics of Brain Changes to Alzheimer's Disease: Sparse Whole Genome Association Scan of Regional MRI Volumes in the ADNI and AddNeuroMed Cohorts. Khondoker M; Newhouse S; Westman E; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Lovestone S; Dobson R; Simmons A; ; J Alzheimers Dis; 2015; 45(3):851-64. PubMed ID: 25649652 [TBL] [Abstract][Full Text] [Related]
8. Effect of HMGCR genetic variation on neuroimaging biomarkers in healthy, mild cognitive impairment and Alzheimer's disease cohorts. Cao L; Wang HF; Tan L; Sun FR; Tan MS; Tan CC; Jiang T; Yu JT; Tan L; Oncotarget; 2016 Mar; 7(12):13319-27. PubMed ID: 26950278 [TBL] [Abstract][Full Text] [Related]
9. HYDRA: Revealing heterogeneity of imaging and genetic patterns through a multiple max-margin discriminative analysis framework. Varol E; Sotiras A; Davatzikos C; Neuroimage; 2017 Jan; 145(Pt B):346-364. PubMed ID: 26923371 [TBL] [Abstract][Full Text] [Related]
10. Classification of Alzheimer's disease and prediction of mild cognitive impairment-to-Alzheimer's conversion from structural magnetic resource imaging using feature ranking and a genetic algorithm. Beheshti I; Demirel H; Matsuda H; Comput Biol Med; 2017 Apr; 83():109-119. PubMed ID: 28260614 [TBL] [Abstract][Full Text] [Related]
12. Genetic study of multimodal imaging Alzheimer's disease progression score implicates novel loci. Scelsi MA; Khan RR; Lorenzi M; Christopher L; Greicius MD; Schott JM; Ourselin S; Altmann A Brain; 2018 Jul; 141(7):2167-2180. PubMed ID: 29860282 [TBL] [Abstract][Full Text] [Related]
13. Convergent Neuroimaging and Molecular Signatures in Mild Cognitive Impairment and Alzheimer's Disease: A Data-Driven Meta-Analysis with N = 3,118. Kang X; Wang D; Lin J; Yao H; Zhao K; Song C; Chen P; Qu Y; Yang H; Zhang Z; Zhou B; Han T; Liao Z; Chen Y; Lu J; Yu C; Wang P; Zhang X; Li M; Zhang X; Jiang T; Zhou Y; Liu B; Han Y; Liu Y; ; Neurosci Bull; 2024 Sep; 40(9):1274-1286. PubMed ID: 38824231 [TBL] [Abstract][Full Text] [Related]
14. Identifying Multimodal Intermediate Phenotypes Between Genetic Risk Factors and Disease Status in Alzheimer's Disease. Hao X; Yao X; Yan J; Risacher SL; Saykin AJ; Zhang D; Shen L; Neuroinformatics; 2016 Oct; 14(4):439-52. PubMed ID: 27277494 [TBL] [Abstract][Full Text] [Related]
15. DNA methylation in the NCAPH2/LMF2 promoter region is associated with hippocampal atrophy in Alzheimer's disease and amnesic mild cognitive impairment patients. Shinagawa S; Kobayashi N; Nagata T; Kusaka A; Yamada H; Kondo K; Nakayama K Neurosci Lett; 2016 Aug; 629():33-37. PubMed ID: 27356276 [TBL] [Abstract][Full Text] [Related]
16. Effects of HLA-DRB1/DQB1 Genetic Variants on Neuroimaging in Healthy, Mild Cognitive Impairment, and Alzheimer's Disease Cohorts. Wang ZX; Wang HF; Tan L; Liu J; Wan Y; Sun FR; Tan MS; Tan CC; Jiang T; Tan L; Yu JT; Mol Neurobiol; 2017 Jul; 54(5):3181-3188. PubMed ID: 27056075 [TBL] [Abstract][Full Text] [Related]
17. Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease. Potkin SG; Guffanti G; Lakatos A; Turner JA; Kruggel F; Fallon JH; Saykin AJ; Orro A; Lupoli S; Salvi E; Weiner M; Macciardi F; PLoS One; 2009 Aug; 4(8):e6501. PubMed ID: 19668339 [TBL] [Abstract][Full Text] [Related]
18. ABCA7 Genotypes Confer Alzheimer's Disease Risk by Modulating Amyloid-β Pathology. Zhao QF; Wan Y; Wang HF; Sun FR; Hao XK; Tan MS; Tan CC; Zhang DQ; Tan L; Yu JT; J Alzheimers Dis; 2016 Mar; 52(2):693-703. PubMed ID: 27003212 [TBL] [Abstract][Full Text] [Related]
20. MS4A6A genotypes are associated with the atrophy rates of Alzheimer's disease related brain structures. Ma J; Zhang W; Tan L; Wang HF; Wan Y; Sun FR; Tan CC; Yu JT; Tan L; Alzheimer's Disease Neuroimaging Initiative Oncotarget; 2016 Sep; 7(37):58779-58788. PubMed ID: 27244883 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]